Cancer Immunology Special Issue

INTRODUCTION Introduction: Cancer Immunology Special Issue—Immunotherapy Yutaka Kawakami Int. Immunol. 2016 28: 317 [Extract] [Full Text] [PDF] [Request Permissions] INVITED REVIEWS The present status and future prospects of peptide-based cancer vaccines Masatoshi Hirayama and Yasuharu Nishimura Int. Immunol. 2016 28: 319-328 [Abstract] [Full Text] [PDF] [Request Permissions] Peptide-based cancer vaccines Vaccine adjuvants as potential cancer immunotherapeutics Burcu Temizoz, Etsushi Kuroda, and Ken J. Ishii Int. Immunol. 2016 28: 329-338 [Abstract] [Full Text] [PDF]  OPEN ACCESS New adjuvants for cancer immunotherapy Immune checkpoint inhibition in ovarian cancer Junzo Hamanishi, Masaki Mandai, and Ikuo Konishi Int. Immunol. 2016 28: 339-348 [Abstract] [Full Text] [PDF] [Request Permissions] Checkpoint inhibition in ovarian cancer T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells Hiroaki Ikeda Int. Immunol. 2016 28: 349-353 [Abstract] [Full Text] [PDF] [Request Permissions] T-cell adoptive immunotherapy Chimeric antigen receptor-modified T cells strike back Matthew J. Frigault and Marcela V. Maus Int. Immunol. 2016 28: 355-363 [Abstract] [Full Text] [PDF] [Request Permissions] CAR-T cells strike back Targeting neoantigens for cancer immunotherapy Yong-Chen Lu and Paul F. Robbins Int. Immunol. 2016 28: 365-370 [Abstract] [Full Text] [PDF] [Request Permissions] Neoantigens in cancer immunotherapy COVER Cover Int. Immunol. 2016 28: NP [PDF] [Request Permissions] STANDING MATERIALS Subscriptions Int. Immunol. 2016 28: NP [PDF] [Request Permissions] Table of Contents Int. Immunol. 2016 28: NP [PDF] [Request Permissions]

Alexandros Sfakianakis
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182

6948891480

alsfakia@gmail.com